Corient Private Wealth’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
25,223
+1,189
+5% +$17.4K ﹤0.01% 2209
2025
Q4
$304K Buy
+24,034
New +$355K ﹤0.01% 2494
2024
Q4
Sell
-8,456
Closed -$237K 2511
2024
Q3
$237K Buy
+8,456
New +$239K ﹤0.01% 2138
2024
Q1
Sell
-10,805
Closed -$251K 2352
2023
Q4
$251K Buy
+10,805
New +$217K ﹤0.01% 1960

Other funds holding RXO

Corient Private Wealth's RXO Position: Q1 2026 in Review

Corient Private Wealth increased its RXO (RXO) stake by 4.9% in Q1 2026, buying an estimated $17.4K and bringing the position to 25,223 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

Corient Private Wealth first reported a position in RXO in Q4 2023 and has held it in 4 quarters since. 274 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Corient Private Wealth held 25,223 shares of RXO worth $369K as of Q1 2026.
  • Corient Private Wealth bought 1,189 RXO shares in Q1 2026, an estimated $17.4K.
  • RXO made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2209 holding.
  • Corient Private Wealth first reported a position in RXO in Q4 2023 and has held it in 4 quarters since.
  • 274 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.